ZBIO · CIK 0001953926 · FY2025 live · 2025-12-31
Zenas BioPharma, Inc.
View as
Model
Classic Z
FY2025
−4.13
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
17.91
0–100 · Classic Z tape · not a PD
Book standing
19
Year change
—
Market PD
—
O-score
15
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
−4.13
Z″ −6.48
Score −4.13 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.751.2 × = 0.90X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−1.991.4 × = −2.79X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.003.3 × = −3.29X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.710.6 × = 1.03X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.031 × = 0.03
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Zenas BioPharma, Inc. is on classic Z at −4.13 (distress) for FY2025, from an SEC 10-K. EBIT / assets is the line that sets the print; retained earnings / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 34th percentile in Healthcare.
- SPRODistressSpero Therapeutics, Inc.−4.08
- GANXDistressGain Therapeutics, Inc.−4.08
- NMADDistressNOMAD POWER SOLUTIONS, INC.−4.07
- ADGMDistressAdagio Medical Holdings, Inc.−4.19
- PLRXDistressPLIANT THERAPEUTICS, INC.−4.20
- INSMDistressINSMED Inc−4.04
- OBIODistressOrchestra BioMed Holdings, Inc.−4.04
- BRNSDistressBarinthus Biotherapeutics plc.−4.02
KPI widgets
Current assets
$351M
Total assets
$384M
Current liabilities
$63M
Total liabilities
$141M
Working capital
$289M
Retained earnings
−$765M
EBIT
−$383M
Total sales
$10M
Book equity
$242M
Accession 0001104659-26-027964. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.